- Patients
- Clinical Research
- Clinical trials
- AAA603-NeoB-Breast
Breast Cancer
AAA603-NeoB-Breast
A Phase I/II open label multi-centre trial of 177Lu Lu-Neo-B in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive oestrogen receptor positive human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with CDK 4/6 inhibitor
Trial overview
Theranostics
Breast Cancer
I/ll
Cabrini (Gandel Wing)
Cabrini Hospital Malvern, Level B4, Gandel Wing, 183 Wattletree Road, Malvern, VIC, 3144, Australia
(03) 9597 6900 cabrinireception@genesiscare.comNuclear Medicine Physician
A/Prof Dinesh Sivaratnam
MBBS FRACP FAANMS, B.Med.Sci.
Cabrini (Gandel Wing)
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.